Patent Law Weblog
recent posts
- Retired Judges File Amicus Brief in Support of Judge Newman
- Hikma v. Amarin at the Supreme Court: The Parties’ Opening Briefs
- Teva Pharmaceuticals International v. Eli Lilly & Co. (Fed. Cir. 2026)
- USPTO Extends Artificial Intelligence Search Automated Pilot Program (ASAP!)
- USPTO Announces That It Has Turned the Corner on Unexamined Application Backlog
about
Month: July 2007
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. Boehringer Ingelheim Pharma GmbH & Co. KG et al. v. Barr Laboratories Inc. et al.1:07-cv-00432; filed July 11, 2007 in the District…
-
By Kevin E. Noonan — It’s beginning to seem like a week cannot go by without The New York Times publishing an article, frequently not on the Op-Ed page but with its news stories, purporting to show that patents are a bad thing – for business, for the country, and sometimes, it seems,…
-
By Donald Zuhn — As we reported on May 9, 2007, the United States Patent and Trademark Office (USPTO) asked for comments on ten topics related to international patent law harmonization. On Wednesday, the USPTO posted the 48 submissions it received, including comments from the Biotechnology Industry Association (BIO) (here), Intellectual Property Owners…
-
July 16-17, 2007 – Pharma and Biotech Collaborative Agreements Conference (American Conference Institute) – San Francisco, CA*** September 18-19, 2007 – Pharma/Biotech Patent Boot Camp (American Conference Institute) – San Francisco, IL*** September 26-27, 2007 – Advanced Forum on Biotech Patents (American Conference Institute) – Boston, MA*** ***Patent Docs is a media sponsor of this…
-
By Donald Zuhn — On Wednesday, the Federal Circuit reversed a District Court judgment that U.S. Patent No. 5,401,741 (the ‘741 patent) was not invalid. In particular, the Federal Circuit held that the District Court clearly erred in determining the level of one of ordinary skill in the art, and as a result,…
-
By Kevin E. Noonan — The measure of sanity displayed by Abbott and Brasil last week, when the parties agreed to a pricing scheme that avoided "breaking" Abbott’s patent on its anti-AIDS drug Kaletra® (see "Brasil Prevails in Dispute with Abbott over AIDS Drug Pricing") has not translated to the Eastern hemisphere. Thailand,…
-
By Kevin E. Noonan — The Federal Circuit invalidated two patents this week on obviousness grounds, overturning a jury verdict that had survived a JMOL motion to the District Court. Surprising about the decision was that it merely referenced KSR Int’l Co. v. Teleflex Inc. as an affirmation of its own jurisprudence, while…
-
By Christopher P. Singer — In a July 10, 2007 announcement, the USPTO announced that the Japan Patent Office (JPO) will become the second foreign office to participate in the priority document exchange program, as of July 28, 2007. As previously reported on Patent Docs, this program allows for the exchange of priority…
-
By Donald Zuhn — As we reported two weeks ago, Roche commenced a cash tender offer on June 27, 2007 to acquire all outstanding shares of Ventana Medical Systems, Inc. common stock. Ventana’s Board of Directors announced today (July 11, 2007) that it had reviewed Roche’s "unsolicited tender offer . . . and…
-
By Jason Derry — The National Institutes of Health (NIH) has announced the creation of a new resource to help promote NIH licensed technologies and technologies supported by funds from the NIH Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs. The resource is Web-based and referred to as the…
Patent Docs 